Wednesday, April 15, 2026, marks the 15th spring cycle of the ICTS NIH Mock Study Section.
Through its Research Development Program, the ICTS offers NIH Mock Study Sections (MSS) that closely simulate an actual NIH study section. These sessions provide detailed, study section–style feedback on complete grant applications for clinical and translational R, K, and F series awards.
| Scientists | 60 |
|---|---|
| R01 | 6 |
| R21 | 5 |
| K08 | 4 |
| R61/R33 | 1 |
| K99 | 1 |
| Total | 17 |
| Observers | 41 |
Team
MSS lead
RDP lead
DPS lead
RDP coordinator
Session Chairs
(Lunch session)
Reviewers
| Tom Baranski, MD, PhD | Margaret Olsen, PhD, MPH | Ganesh Chand, PhD | Angela Brown, MD |
| Roger Yusen, MD | Miranda Orr, PhD | Andrew Davis, MD | Patty Cavazos Rehg, PhD |
| Ream Al-Hasani, PhD | Jacqueline Payton, MD, PhD | Alex Everhart, PhD | Takeshi Egawa, MD, PhD |
| Jacco Boon, PhD | Benjamin Philip, PhD | Michael Greenberg, PhD | Seth Eisen, MD |
| Derek Byers, MD, PhD | Jennifer Philips, MD, PhD | Sarah Hartz, MD, PhD | Kimberly Enard, PhD |
| Chih-Hung Chang, PhD | Chihiro Sato, PhD | Ben Humphreys, MD, PhD | Elvin Geng, MD, MPH |
| John Cirrito, PhD | Nancy Sweitzer, MD, PhD | Sunny Lin, PhD | Mae Gordon, PhD |
| Chuck Goss, PhD | Adetunji Toriola, MD, PhD | Cynthia Ma, MD, PhD | Aimee James, PhD, MPH |
| David Hunstad, MD | Stephanie Fritz, MD, MSCI | Philip Miller | Lindsay Kuroki, MD, MSCI |
| Catherine Lang, PhD | Dominic Reeds, MD | Kahuro Sumino, MD | Timothy McBride, PhD |
| Erin Linnenbringer, PhD | Deborah Lenschow, MD, PhD | Rachel Tabak, PhD | Jenny McKenzie, PhD |
| Phillip Marotta, PhD, MPH | Arpana Agrawal, PhD | Neil White, MD | Russell Pachynski, MD |
| Kerri Morgan, PhD | Fadh Ahmad, MD | Steve Brody, MD | Shalini Shenoy, MD |
| Rick Stein, PhD | Siobhan Sutcliffe, PhD | Michael Thompson, MD, PhD | Carissa van den Berk Clark, PhD |
| Jay Piccirillo, MD | Jennifer Harlow | Rafael Galindo, MD, PhD | Jacqui Hawkins, PhD |
| Janine Bijsterbosch, PhD |
Thank you to everyone who contributed. The ICTS is deeply grateful to the applicants, reviewers, staff, and leadership whose efforts made it possible to provide rigorous, study section–style feedback that will strengthen clinical and translational R, K, and F series grant applications across our community.